Post Office Boosts Breast Cancer Stamp
WASHINGTON-Sales of the 40-cent Breast Cancer stamp generated $5.2 million for breast cancer research in the first 7 months following its release in July 1998. The US Postal Service plans a sales campaign tied to Mother’s Day, and it will promote the stamp in partnership with the Revlon Run/Walk for Women fund-raiser in Los Angeles and New York City
WASHINGTONSales of the 40-cent Breast Cancer stamp generated $5.2 million for breast cancer research in the first 7 months following its release in July 1998. The US Postal Service plans a sales campaign tied to Mothers Day, and it will promote the stamp in partnership with the Revlon Run/Walk for Women fund-raiser in Los Angeles and New York City
Funds from the stamps sale above the regular cost of a first-class stamp, now 33 cents, go the National Institutes of Health (70%) and Department of Defense (30%) for breast cancer research
Experts Discuss Differences in Radiotherapy Outcomes in BRCA+ Breast Cancer
October 30th 2023Rebecca M. Shulman, MD, and Zachary Kiss, DO, discuss findings from a study evaluating differences in outcomes with radiotherapy and disease characteristics of patients with breast cancer harboring BRCA mutations compared with those without mutated disease.
FDA Approves Capivasertib Plus Fulvestrant in Advanced HR+, HER2– Breast Cancer
November 16th 2023Patients with locally advanced or metastatic breast cancer that is hormone receptor–positive, HER2-negative breast cancer with 1 or more PIK3CA, AKT1, or PTEN alterations may now receive capivasertib plus fulvestrant.
Oncology On-The-Go Podcast: De-escalating Breast Cancer Treatment
May 8th 2023Rakhshanda Rahman, MD, FRCS, FACS, emphasizes the importance of educating patients and physicians on the potential risks and benefits of new approaches and technologies involved in the de-escalation of breast cancer treatment.
